VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 3, 2016) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care ...
September 7, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a next-generation sternal intraosseous infusion system (FASTx; Pyng Medical Corp). The device is ...
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Type (Manual IO Needles, Battery Powered Driver), By End-use (Hospitals and ...
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts ...
The global intraosseous infusion devices market is on a strong growth trajectory, with projections indicating a significant rise from USD 5,065.8 million in 2025 to USD 10,463.8 million by 2035. This ...
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/03/16 -- Pyng Medical Corp. (TSX VENTURE: PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical ...